Takeda Pharmaceutical Co. (TAK)
(Delayed Data from NYSE)
$14.28 USD
+0.06 (0.42%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $14.27 -0.01 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
A Value D Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Takeda Pharmaceutical Co. [TAK]
Reports for Purchase
Showing records 1 - 15 ( 15 total )
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Key Takeaways from KOL Panels at Our Immune Cell Engager Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended November 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for TAK 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended November 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended October 20.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended October 13.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended September 22.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended July 28.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended July 21.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 30.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 23.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 9.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Weekly Retail Sales Tracker for Solid Tumors - Week Ended April 7.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
Does Smoke from CD47 Program at SITC Signal Further Flames at ASH?
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Takeda Pharmaceutical Co.
Industry: Medical - Drugs
|